Browse by Series:

Choosing Frontline and Second-line Therapy for NSCLC

Mark A. Socinski, MD
Published: Wednesday, May 17, 2017



Mark A. Socinski, MD, Florida Hospital Cancer Institute, discusses how to decide first-line therapy, second-line therapy, and beyond for patients with non–small cell lung cancer.
SELECTED
LANGUAGE
Slider Left
Slider Right


Mark A. Socinski, MD, Florida Hospital Cancer Institute, discusses how to decide first-line therapy, second-line therapy, and beyond for patients with non–small cell lung cancer.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum OnlineJan 31, 20191.5
Community Practice Connections™: Current Status and the Future Potential of CAR T-Cell Therapy for Lymphoid Malignancies: The Experts Weigh-In on Recent Data and Clinical ExperienceJan 31, 20192.0
Publication Bottom Border
Border Publication
x